Big Gain For Xenetic Biosciences, Inc.
Wed, Dec 09, 2020 at 05:30 PM
Xenetic Biosciences, Inc. (XBIO:NASDAQ) soared at $3.17, a gain of 193.5%. The stock appeared on our News Catalysts scanner on Wed 09 Dec 20 at 02:34 PM in the 'MISCELLANEOUS' category. From Tue 24 Nov 20, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Mon 20 Jul 20 at $1.8 with a volume of 9M+, and its share price has been moving sideways in recent weeks.
About Xenetic Biosciences, Inc. (XBIO:NASDAQ)
Xenetic Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics.
Top 10 Gainers:
- GLSI (GLSI:NASDAQ), 998.08%
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 193.52%
- Arlington Asset Investment Corp. (AI:NYSE), 120.21%
- SV (SV:NASDAQ), 100%
- DoorDash Inc (DASH:NASDAQ), 85.79%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 83.39%
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 73.17%
- MTS Systems Corporation (MTSC:NASDAQ), 51.84%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 39.04%
- Tuscan Holdings Corp. (THCB:NASDAQ), 34.59%